International Journal of Women''s Dermatology最新文献

英文中文

Vulvar allergic contact dermatitis to multiple acrylates: a case report. 多发性丙烯酸酯外阴过敏性接触性皮炎1例。

Q2 Medicine

International Journal of Women''s Dermatology

Pub Date : 2023-03-01 DOI: 10.1097/JW9.0000000000000077

Núria Riera-Martí, Vicente Expósito-Serrano, Maria Sin, Marta Gamissans, Cristina López-Llunell, Miquel Ribera

引用次数: 1

Patterns of insurance coverage for wigs in patients with alopecia areata: a cross-sectional survey. 斑秃患者假发保险覆盖模式:横断面调查。

Q2 Medicine

International Journal of Women''s Dermatology

Pub Date : 2023-03-01 DOI: 10.1097/JW9.0000000000000075

Ogechi Ezemma, Shivali Devjani, Aidan Lee, Kristen J Kelley, Lisa Anderson, Nicole Friedland, Maryanne Senna

引用次数: 0

A cross-sectional study of contact allergens in feminine hygiene wipes: a possible cause of vulvar contact dermatitis. 女性卫生湿巾接触性过敏原的横断面研究:外阴接触性皮炎的可能原因。

Q2 Medicine

International Journal of Women''s Dermatology

Pub Date : 2022-12-01 DOI: 10.1097/JW9.0000000000000060

Jazmin Newton, Sophie Richardson, Annika M van Oosbre, Jiade Yu, Channi Silence

Feminine hygiene wipes marketed toward women for maintaining freshness and cleanliness of the vulva and perineum are abundant both in-store and online. Many of these products boast being "fragrance free," "gentle," and "for sensitive skin," which is attractive to consumers. However, these claims do not necessarily mean they are free of potential allergens.

Objective: The present study aims to investigate the presence and prevalence of potential allergens in the most used feminine hygiene wipes.

Methods: An internet-based search was performed to identify best-selling name brand and generic feminine hygiene wipes. Each unique wipe was analyzed and compared to the North American Contact Dermatitis Group 80 allergens.

Results: We found contact allergens are frequently present in feminine hygiene wipes, most commonly fragrances, other scented botanicals in the form of essences, oils, and fruit juices, and vitamin E (tocopherol). All wipes analyzed in this study contained potential allergens.

Limitations: The inability to eliminate commercial names from analysis could have introduced bias.

Conclusions: Vaginal and vulvar epithelia are highly susceptible to contact allergens, often found in products marketed for feminine hygiene and cleanliness. Providers should caution patients against trusting product labeling claims to avoid incidental contact allergy and encourage simply cleansing the vulva with water.

女性卫生湿巾面向女性销售，用于保持外阴和会阴的新鲜和清洁，无论是在商店还是在网上都比比皆是。这些产品中很多都标榜“无香味”、“温和”、“适合敏感皮肤”，这对消费者很有吸引力。然而，这些说法并不一定意味着它们没有潜在的过敏原。目的:本研究旨在调查最常用女性卫生湿巾中潜在过敏原的存在和流行情况。方法:以互联网为基础进行搜索，以确定最畅销的品牌和通用女性卫生湿巾。每个独特的擦拭进行分析，并与北美接触性皮炎组80过敏原进行比较。结果:我们发现接触性过敏原经常存在于女性卫生湿巾中，最常见的是香水，其他有香味的植物药，精油，果汁和维生素E(生育酚)。本研究分析的所有湿巾都含有潜在的过敏原。局限性:无法从分析中消除商业名称可能会引入偏差。结论:阴道和外阴上皮极易受到接触性过敏原的影响，这些过敏原通常存在于市场上销售的女性卫生和清洁产品中。提供者应该提醒患者不要相信产品标签上的声明，以避免意外的接触性过敏，并鼓励简单地用水清洗外阴。

{"title":"A cross-sectional study of contact allergens in feminine hygiene wipes: a possible cause of vulvar contact dermatitis.","authors":"Jazmin Newton, Sophie Richardson, Annika M van Oosbre, Jiade Yu, Channi Silence","doi":"10.1097/JW9.0000000000000060","DOIUrl":"https://doi.org/10.1097/JW9.0000000000000060","url":null,"abstract":"Feminine hygiene wipes marketed toward women for maintaining freshness and cleanliness of the vulva and perineum are abundant both in-store and online. Many of these products boast being \"fragrance free,\" \"gentle,\" and \"for sensitive skin,\" which is attractive to consumers. However, these claims do not necessarily mean they are free of potential allergens.Objective: The present study aims to investigate the presence and prevalence of potential allergens in the most used feminine hygiene wipes.Methods: An internet-based search was performed to identify best-selling name brand and generic feminine hygiene wipes. Each unique wipe was analyzed and compared to the North American Contact Dermatitis Group 80 allergens.Results: We found contact allergens are frequently present in feminine hygiene wipes, most commonly fragrances, other scented botanicals in the form of essences, oils, and fruit juices, and vitamin E (tocopherol). All wipes analyzed in this study contained potential allergens.Limitations: The inability to eliminate commercial names from analysis could have introduced bias.Conclusions: Vaginal and vulvar epithelia are highly susceptible to contact allergens, often found in products marketed for feminine hygiene and cleanliness. Providers should caution patients against trusting product labeling claims to avoid incidental contact allergy and encourage simply cleansing the vulva with water.","PeriodicalId":53478,"journal":{"name":"International Journal of Women''s Dermatology","volume":"8 4","pages":"e060"},"PeriodicalIF":0.0,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9699505/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10463330","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Cognitive behavior therapy as dermatological treatment: a narrative review. 认知行为疗法作为皮肤病治疗:述评。

Q2 Medicine

International Journal of Women''s Dermatology

Pub Date : 2022-12-01 DOI: 10.1097/JW9.0000000000000068

Rishab R Revankar, Nikita R Revankar, Esther A Balogh, Heli A Patel, Sebastian G Kaplan, Steven R Feldman

Cognitive behavior therapy (CBT) is efficacious in treating numerous psychological disorders. It is also effective in combination with medication for chronic pain, diabetes, and other diseases. Patients with skin disease report high levels of stress, anxiety, and negative feelings.

Objective: To summarize the findings on the utility of CBT for the improvement of skin status and quality of life in patients with dermatological conditions.

Methods: PubMed and Google Scholar databases were searched for relevant articles from database inception to the time of search (October 20, 2021). A total of 30 included studies featured 10 on psoriasis, 11 on atopic dermatitis, 4 on vitiligo, 4 on acne, and 1 study on alopecia areata.

Results: Several studies, including randomized controlled trials with large study samples, support the effectiveness of CBT and Internet CBT for a number of dermatological conditions. Patients who completed CBT courses were less likely to rely on dermatological healthcare during follow-up.

Limitations: There are a limited number of studies discussing the implementation of CBT for alopecia, acne, and vitiligo.

Conclusion: Patients who underwent CBT or Internet CBT in addition to skin care demonstrated improvement with quality of life and severity of skin disease as compared to controls only receiving standard of care treatment.

认知行为疗法(CBT)是治疗多种心理障碍的有效方法。它与治疗慢性疼痛、糖尿病和其他疾病的药物联合使用也很有效。皮肤病患者报告有高度的压力、焦虑和消极情绪。目的:总结认知行为疗法在改善皮肤病患者皮肤状况和生活质量方面的应用。方法:检索PubMed和Google Scholar数据库自建库至检索时间(2021年10月20日)的相关文章。总共包括30项研究，其中10项针对牛皮癣，11项针对特应性皮炎，4项针对白癜风，4项针对痤疮，1项针对斑秃。结果:几项研究，包括大样本随机对照试验，支持CBT和网络CBT对许多皮肤病的有效性。完成CBT课程的患者在随访期间不太可能依赖皮肤科保健。局限性:讨论CBT治疗脱发、痤疮和白癜风的研究数量有限。结论:与仅接受标准护理治疗的对照组相比，接受CBT或网络CBT治疗的患者在生活质量和皮肤病严重程度方面均有改善。

{"title":"Cognitive behavior therapy as dermatological treatment: a narrative review.","authors":"Rishab R Revankar, Nikita R Revankar, Esther A Balogh, Heli A Patel, Sebastian G Kaplan, Steven R Feldman","doi":"10.1097/JW9.0000000000000068","DOIUrl":"https://doi.org/10.1097/JW9.0000000000000068","url":null,"abstract":"Cognitive behavior therapy (CBT) is efficacious in treating numerous psychological disorders. It is also effective in combination with medication for chronic pain, diabetes, and other diseases. Patients with skin disease report high levels of stress, anxiety, and negative feelings.Objective: To summarize the findings on the utility of CBT for the improvement of skin status and quality of life in patients with dermatological conditions.Methods: PubMed and Google Scholar databases were searched for relevant articles from database inception to the time of search (October 20, 2021). A total of 30 included studies featured 10 on psoriasis, 11 on atopic dermatitis, 4 on vitiligo, 4 on acne, and 1 study on alopecia areata.Results: Several studies, including randomized controlled trials with large study samples, support the effectiveness of CBT and Internet CBT for a number of dermatological conditions. Patients who completed CBT courses were less likely to rely on dermatological healthcare during follow-up.Limitations: There are a limited number of studies discussing the implementation of CBT for alopecia, acne, and vitiligo.Conclusion: Patients who underwent CBT or Internet CBT in addition to skin care demonstrated improvement with quality of life and severity of skin disease as compared to controls only receiving standard of care treatment.","PeriodicalId":53478,"journal":{"name":"International Journal of Women''s Dermatology","volume":"8 4","pages":"e068"},"PeriodicalIF":0.0,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/1f/38/jw9-8-e068.PMC9788967.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10856510","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 3

Lipschütz ulceration in a 12-year-old girl following second dose of Comirnaty (Pfizer) COVID-19 vaccine. 一名12岁女孩在第二剂辉瑞公司COVID-19疫苗后出现lipsch<e:1>溃疡。

Q2 Medicine

International Journal of Women''s Dermatology

Pub Date : 2022-12-01 DOI: 10.1097/JW9.0000000000000066

Aaron J Frederiks, Rachael S Foster, Bernadette Ricciardo

引用次数: 2

Integrating primary palliative care into hidradenitis suppurativa management. 将初级姑息治疗纳入化脓性汗腺炎管理。

Q2 Medicine

International Journal of Women''s Dermatology

Pub Date : 2022-12-01 DOI: 10.1097/JW9.0000000000000063

Terri Shih, Monica Zell, Daniel Karlin, Devea R De, Jan Smogorzewski, Vivian Y Shi, Jennifer L Hsiao

Hidradenitis suppurativa (HS) is a chronic, often debilitating skin condition that disproportionately impacts women in the United States and other Western nations. Dermatologists should consider incorporating palliative care principles into HS management to optimize care. Primary palliative care principles include utilizing evidence-based frameworks in serious illness communication, acknowledging and addressing physical and psychosocial suffering, recognizing and validating the burden of disease in partners, families, and caregivers, and engaging in collaborative care coordination. Certain patients may also benefit from outpatient, or sometimes inpatient, palliative care specialist collaboration, such as those with refractory HS and superimposed challenging psychosocial dynamics and symptom burden. Through integration of these palliative care domains into HS care, dermatologists can optimize their ability to provide comprehensive and compassionate care for patients suffering with this disease.

化脓性汗腺炎(HS)是一种慢性，经常使皮肤衰弱的疾病，对美国和其他西方国家的女性影响很大。皮肤科医生应考虑将姑息治疗原则纳入HS管理，以优化护理。初级姑息治疗原则包括在严重疾病沟通中利用循证框架，承认和解决身体和心理痛苦，承认和确认伴侣、家庭和照顾者的疾病负担，以及参与协作性护理协调。某些患者也可能受益于门诊，或有时住院，姑息治疗专家合作，如那些难治性HS和叠加具有挑战性的心理社会动力学和症状负担。通过将这些姑息治疗领域整合到HS护理中，皮肤科医生可以优化他们为患有这种疾病的患者提供全面和富有同情心的护理的能力。

{"title":"Integrating primary palliative care into hidradenitis suppurativa management.","authors":"Terri Shih, Monica Zell, Daniel Karlin, Devea R De, Jan Smogorzewski, Vivian Y Shi, Jennifer L Hsiao","doi":"10.1097/JW9.0000000000000063","DOIUrl":"https://doi.org/10.1097/JW9.0000000000000063","url":null,"abstract":"Hidradenitis suppurativa (HS) is a chronic, often debilitating skin condition that disproportionately impacts women in the United States and other Western nations. Dermatologists should consider incorporating palliative care principles into HS management to optimize care. Primary palliative care principles include utilizing evidence-based frameworks in serious illness communication, acknowledging and addressing physical and psychosocial suffering, recognizing and validating the burden of disease in partners, families, and caregivers, and engaging in collaborative care coordination. Certain patients may also benefit from outpatient, or sometimes inpatient, palliative care specialist collaboration, such as those with refractory HS and superimposed challenging psychosocial dynamics and symptom burden. Through integration of these palliative care domains into HS care, dermatologists can optimize their ability to provide comprehensive and compassionate care for patients suffering with this disease.","PeriodicalId":53478,"journal":{"name":"International Journal of Women''s Dermatology","volume":"8 4","pages":"e063"},"PeriodicalIF":0.0,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/a2/82/jw9-8-e063.PMC9760599.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10456813","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Alopecia areata incognita: clinical characteristics and use of the Sinclair shedding scale. 隐蔽性斑秃:临床特点和辛克莱脱落秤的使用。

Q2 Medicine

International Journal of Women''s Dermatology

Pub Date : 2022-12-01 DOI: 10.1097/JW9.0000000000000067

Maya S Collins, Shaheir Ali, Kristen Kelley, Maryanne Makredes Senna

Introduced in 1987, alopecia areata incognita (AAI), is incredibly difficult to diagnose. It presents as persistent, diffuse hair shedding while patients maintain normal hair density.1,2 We report 4 cases of AAI diagnosed in our specialty alopecia clinic, highlighting aspects of the condition that impart high levels of diagnostic suspicion. A chart review conducted between December 2017 and March 2022 yielded 4 patients with AAI. All patients were Caucasian females, average age of 45.3 years (SD = 10.9), with several years of excess scalp hair shedding. They denied telogen effluvium (TE) triggers or patchy hair loss. Initial differential diagnoses included female pattern hair loss (FPHL) and chronic telogen effluvium. Despite diligent treatment with >6 months oral spironolactone and/or oral low dose minoxidil, patients reported no improvement in shedding. All patients were noted to have a distinctive global appearance: normal density of 5–6-cm length terminal hairs on the top of the scalp and dramatically decreased density of longer terminal hairs distally (Fig. 1). Trichoscopy was unrevealing. AAI patients may develop circular patches of classic alopecia areata, but this was not observed in our initial evaluations.2,3 Scalp biopsies in all 4 patients varied with findings and the respective dermatopathologist favored diagnoses are listed in Table 1. Biopsy findings in AAI are subtle and vary depending on the disease stage.4,5 Histopathology in our patients was insufficient for a definitive diagnosis of alopecia areata incognita. Patients with AAI may collect 350–1000 hairs per day using the modified wash test.6 As the modified wash test is notably time consuming and difficult, we utilized the Sinclair shedding scale (SSS) to assess hair shedding.7 All patients reported >Grade 6 daily shedding on the SSS, representing about 750 hairs per day.7 Given our suspicion for AAI, we added monthly intralesional corticosteroid scalp injections at 5 mg/mL doses across the scalp. Patients did not use adjunct topical corticosteroids. After 2 treatment sessions, all patients reported SSS score improvement to the normal range and increased distal hair density (Fig. 1). One patient developed a few patches of subcentimeter classic alopecia areata that subsequently improved. Several AAI publications emphasize diagnosis based on growth phases and trichoscopy.2,3 We highlight an AAI clinical phenotype and demonstrate utility of the SSS when AAI is suspected. Originally developed to aid diagnosis of FPHL, the SSS is useful in assessing the response to treatment in women with varying hair lengths. Given that our patients had straight hair without improved SSS scores despite adequate treatment of FPHL, the SSS provided critical clinical estimates of shedding without extensive effort from patients or providers. The SSS

{"title":"Alopecia areata incognita: clinical characteristics and use of the Sinclair shedding scale.","authors":"Maya S Collins, Shaheir Ali, Kristen Kelley, Maryanne Makredes Senna","doi":"10.1097/JW9.0000000000000067","DOIUrl":"https://doi.org/10.1097/JW9.0000000000000067","url":null,"abstract":"Introduced in 1987, alopecia areata incognita (AAI), is incredibly difficult to diagnose. It presents as persistent, diffuse hair shedding while patients maintain normal hair density.1,2 We report 4 cases of AAI diagnosed in our specialty alopecia clinic, highlighting aspects of the condition that impart high levels of diagnostic suspicion. A chart review conducted between December 2017 and March 2022 yielded 4 patients with AAI. All patients were Caucasian females, average age of 45.3 years (SD = 10.9), with several years of excess scalp hair shedding. They denied telogen effluvium (TE) triggers or patchy hair loss. Initial differential diagnoses included female pattern hair loss (FPHL) and chronic telogen effluvium. Despite diligent treatment with >6 months oral spironolactone and/or oral low dose minoxidil, patients reported no improvement in shedding. All patients were noted to have a distinctive global appearance: normal density of 5–6-cm length terminal hairs on the top of the scalp and dramatically decreased density of longer terminal hairs distally (Fig. 1). Trichoscopy was unrevealing. AAI patients may develop circular patches of classic alopecia areata, but this was not observed in our initial evaluations.2,3 Scalp biopsies in all 4 patients varied with findings and the respective dermatopathologist favored diagnoses are listed in Table 1. Biopsy findings in AAI are subtle and vary depending on the disease stage.4,5 Histopathology in our patients was insufficient for a definitive diagnosis of alopecia areata incognita. Patients with AAI may collect 350–1000 hairs per day using the modified wash test.6 As the modified wash test is notably time consuming and difficult, we utilized the Sinclair shedding scale (SSS) to assess hair shedding.7 All patients reported >Grade 6 daily shedding on the SSS, representing about 750 hairs per day.7 Given our suspicion for AAI, we added monthly intralesional corticosteroid scalp injections at 5 mg/mL doses across the scalp. Patients did not use adjunct topical corticosteroids. After 2 treatment sessions, all patients reported SSS score improvement to the normal range and increased distal hair density (Fig. 1). One patient developed a few patches of subcentimeter classic alopecia areata that subsequently improved. Several AAI publications emphasize diagnosis based on growth phases and trichoscopy.2,3 We highlight an AAI clinical phenotype and demonstrate utility of the SSS when AAI is suspected. Originally developed to aid diagnosis of FPHL, the SSS is useful in assessing the response to treatment in women with varying hair lengths. Given that our patients had straight hair without improved SSS scores despite adequate treatment of FPHL, the SSS provided critical clinical estimates of shedding without extensive effort from patients or providers. The SSS","PeriodicalId":53478,"journal":{"name":"International Journal of Women''s Dermatology","volume":"8 4","pages":"e067"},"PeriodicalIF":0.0,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9788966/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10856512","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Travel burden on patients at a subspecialty hidradenitis suppurativa clinic: a single-center retrospective study. 亚专科化脓性汗腺炎门诊患者的旅行负担:一项单中心回顾性研究

Q2 Medicine

International Journal of Women''s Dermatology

Pub Date : 2022-12-01 DOI: 10.1097/JW9.0000000000000027

Diana S Kim, Nicole Giannotti, Prerna Salian, Alexa B Kimball, Martina L Porter

引用次数: 0

A solitary asymptomatic patch on the palm. 手掌上一个孤立的无症状斑块。

Q2 Medicine

International Journal of Women''s Dermatology

Pub Date : 2022-11-28 eCollection Date: 2022-12-01 DOI: 10.1097/JW9.0000000000000062

Sara B Huff, Alisha N Plotner

A woman in her mid 60s presented for an asymptomatic pink depressed patch on her left thenar eminence. It had been present for 10 years and gradually enlarged. She denied a history of trauma or other local exposure that could have contributed to the formation of the lesion. Her medical history included arthritis, hypertension, hyperlipidemia, and mallet finger of the right hand. She denied any history of skin cancer. Physical examination was notable for a 3 × 2-cm well-demarcated mildly erythematous patch on her left thenar eminence with a raised scaly border (Fig. 1). A biopsy specimen of the peripheral border was obtained for histopathologic analysis (Fig. 2).

引用次数: 0

Painful fissured plaque in a girl with Crohn's disease. 一个患有克罗恩病的女孩的痛苦的裂化斑块。

Q2 Medicine

International Journal of Women''s Dermatology

Pub Date : 2022-11-21 eCollection Date: 2022-12-01 DOI: 10.1097/JW9.0000000000000065

Meshal M Alhameedy, Areen M Alhemedy

A 16-year-old Saudi girl diagnosed with Crohn’s disease (CD) when she was 10 years old, receiving infliximab (5 mg/kg IV) every 8 weeks for 2 years, presented with a painful cutaneous eruption in the posterior auricular region for the last 6 months. Examination found hyperkeratotic eroded fissured crusted erythematous plaque in the left posterior auricular area extending to the earlobe (Fig. 1A), progressively increasing over the last 6 months, associated with moderate to severe pain and mild pruritus. Dermatoscopic examination revealed uniform dotted vessels and a white-to-yellowish scale. There was no involvement of the scalp, oral and nasal mucosa, genitalia, or nails. Histopathological analyses (Fig. 1B) were performed. Special stains using Periodic acid-Schiff and Grocott methenamine silver revealed no organisms. However, tissue culture and swab for culture and sensitivity grew methicillin-susceptible Staphylococcus aureus. Basic laboratory panels, including complete blood count, liver and renal function tests, hepatitis B and C and HIV serology, purified protein derivative testing, and chest X-ray, were normal.

{"title":"Painful fissured plaque in a girl with Crohn's disease.","authors":"Meshal M Alhameedy, Areen M Alhemedy","doi":"10.1097/JW9.0000000000000065","DOIUrl":"https://doi.org/10.1097/JW9.0000000000000065","url":null,"abstract":"A 16-year-old Saudi girl diagnosed with Crohn’s disease (CD) when she was 10 years old, receiving infliximab (5 mg/kg IV) every 8 weeks for 2 years, presented with a painful cutaneous eruption in the posterior auricular region for the last 6 months. Examination found hyperkeratotic eroded fissured crusted erythematous plaque in the left posterior auricular area extending to the earlobe (Fig. 1A), progressively increasing over the last 6 months, associated with moderate to severe pain and mild pruritus. Dermatoscopic examination revealed uniform dotted vessels and a white-to-yellowish scale. There was no involvement of the scalp, oral and nasal mucosa, genitalia, or nails. Histopathological analyses (Fig. 1B) were performed. Special stains using Periodic acid-Schiff and Grocott methenamine silver revealed no organisms. However, tissue culture and swab for culture and sensitivity grew methicillin-susceptible Staphylococcus aureus. Basic laboratory panels, including complete blood count, liver and renal function tests, hepatitis B and C and HIV serology, purified protein derivative testing, and chest X-ray, were normal.","PeriodicalId":53478,"journal":{"name":"International Journal of Women''s Dermatology","volume":" ","pages":"e065"},"PeriodicalIF":0.0,"publicationDate":"2022-11-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/cd/06/jw9-8-e065.PMC9678592.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40702400","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

首页上一页

下一页尾页

类型

全部化学•材料生命科学医学物理工程技术环境•农林材料科学地球科学法学管理学化学环境科学与生态学计算机科学教育学经济学农林科学人文科学生物学数学物理与天体物理心理学综合性期刊其他工业工程理学历史学农学文学信息工程

数据库

全部 ACS Publications Elsevier ieeexplore Springer The Royal Society of Chemistry Wiley

期刊

International Journal of Women''s Dermatology

全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.

﹀